CD79a (B-Cell Marker); Clone JCB117 (Concentrate)

Specificity: Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20). This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well.
Immunogen: A synthetic peptide corresponding to aa 202-216 (GTYQDVGSLNIADVQ) of human CD79a protein.

• Artikelnummer: SCYRA0067-C.5
• Hersteller: ScyTek Laboratories
• Hersteller Artikelnummer: RA0067-C.5
• Verpackungseinheit: 0,5 ml
• Mengeneinheit: STK
• Reaktivität: Human
• Isotyp: IgG1
• Wirt: Mouse